Trilantic Europe Completes Sale of Domixtar Pharmaceutical
Deal News | Aug 07, 2025 | Trilantic Europe
Trilantic Europe has successfully completed the sale of Domixtar Pharmaceutical, a major player in the pharmaceutical industry, to Azzurra Capital and The Club Dealers. The transaction involves the full divestment by Trilantic Europe and Alto Partners. Alongside this deal, Trilantic Europe has hired a new Partner to lead their Energy Transition Investments strategy, signaling a shift in focus towards sustainable and renewable energy sectors.
Sectors
- Pharmaceuticals
- Private Equity
- Energy Transition
Geography
- Europe – Trilantic Europe is a key player in the transactions, indicating a European focus.
Industry
- Pharmaceuticals – The article involves the acquisition of Domixtar Pharmaceutical, underscoring its relevance to the pharmaceutical industry.
- Private Equity – Trilantic Europe and their divestment of Domixtar Pharmaceutical, alongside hiring a new partner for strategic investment, place the article within the private equity sector.
- Energy Transition – Trilantic Europe's hiring of a new partner to head an energy transition strategy highlights their focus on the energy transition sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Trilantic Europe | Selling Company | Companies | A private equity firm involved in the sale of Domixtar Pharmaceutical and the hiring of a new partner for energy strategies. |
| Azzurra Capital | Bidding Company/Buyer | Companies | One of the acquiring firms of Domixtar Pharmaceutical. |
| The Club Dealers | Bidding Company/Buyer | Companies | Joint acquirer of Domixtar Pharmaceutical alongside Azzurra Capital. |
| Domixtar Pharmaceutical | Target Company | Companies | A leader in the pharmaceutical industry acquired by Azzurra Capital and The Club Dealers. |
| Alto Partners | Selling Company | Companies | Another firm divesting their stake in Domixtar Pharmaceutical. |